Performance overview
Value at beginning of month: $168,637.53
Value at end of month: $160,225.58
Month over month change: -4.99%
Total IRR: 28.90%
Related indices, monthly change
NASDAQ: -0.78%
IVV (iShares Core S&P 500): +0.54%
IBB (iShares NASDAQ Biotechnology Index): -0.18%
MXI (iShares Global Materials): +0.94%
VEGI (iShares MSCI Global Agriculture Producers): +2.21%
ICLN (iShares Clean Energy): -1.38%
Individual performances
The CSSBI badly underperformed all the comparable indices during September, and has almost given up the lead they had against these indices from the first part of the year. While most of the companies lost between 5% and 20% of their value, there was one positive standout in the group. Synlogic, who is developing living medicines, announced positive interim Phase I/IIa study data, which led to the company’s stock increasing 34% over the course of the month.
Changes made to index
None.
You can view the index here.
Allocation as of October 5, 2018
